Table 2 The clinicopathological features of patients with bladder cancer and health controls
Characteristics | Patients(n = 271) | Controls(n = 381) | P value |
|---|---|---|---|
Age | |||
Median (first quartile, third quartile) | 66 (56,73) | 60 (49,75) | 0.093 |
age ≤ median(63)(n[%]) | 120[44.28%] | 211[55.38%] | <0.01 |
age> median(63)(n[%]) | 151[55.72%] | 170[44.62%] | |
Sex (n[%]) | |||
Male | 216[79.70%] | 183[48.03%] | <0.001 |
Female | 55[20.30%] | 198[51.97%] | |
Smoking status (n[%]) | |||
Smoker | 141[52.03%] | 188[49.34%] | 0.551 |
Nonsmoker | 130[47.97%] | 193[50.66%] | |
Tumor stage (n[%]) | |||
MIBC | 131[48.34%] | ||
NMIBC | 140[51.66%] | ||
Tumor grade (n[%]) | |||
High grade | 162[59.78%] | ||
Low grade | 109[40.22%] | ||
Clinical stage (n[%]) | |||
I(Ta-T1N0m0) | 140[51.66%] | ||
II(T2N0M0) | 77[28.41%] | ||
III(T3N0M0, T4aN0M0) | 33[12.18%] | ||
IV(T4bN0M0, TnNnM0,TnNnMn, n ≥ 1) | 21[7.75%] |